Refine/Revise Search

Here are some other businesses that you may be interested in:

Asking Price: $1,000,000

Founder-Built PropTech AI Platform Proprietary IP

Not Disclosed, Not Disclosed
Not disclosed

Founder-built, production-ready PropTech AI platform developed by experienced software engineers with a focus on proprietary data, algorithms, and product performance. The technology is fully built, live, and scalable, incorporating trade-secret datasets and custom AI models designed for advanced spatial and market intelligence. The platform has demonstrated consistent organic user adoption but has not implemented a formal go-to-market strategy, paid marketing, or enterprise sales effort. This is an IP and technology, ideal for a strategic or operator buyer seeking to monetize and scale without the time, cost, or risk of building internally.Key Highlights:-Proprietary datasets, algorithms, and AI models maintained as trade secrets-Fully built, live platform with scalable architecture-Growing organic user adoption with no marketing spend-Recently released agentic AI chat interface allowing natural-language interaction-Built by technical founders focused on engineering, not commercialization-Multiple potential monetization paths (SaaS, licensing, API, internal deployment)-Best suited for strategic acquirers, PropTech operators, or venture studiosFinal Broker Note:Acquire a fully developed AI platform with proprietary IP and real user traction. Ideal for a buyer seeking a head start rather than a blank slate.

Cash Flow Not Disclosed
Revenue Not Disclosed

Asking Price: $1,199,000

PROFITABLE DNA NUTRITION PLATFORM 10,000 USERS

Not Disclosed, Not Disclosed
Not disclosed

A profitable, founder-built precision-nutrition platform that has sold its core product every day for eight years. The company translates a customer's DNA into a practical, personalized way of eating. A proprietary algorithm classifies each customer into one of twenty named diet types, then generates a personalized meal plan and nutrition protocol built around how that individual actually metabolizes fat, carbohydrate, protein, caffeine, histamine, and dietary cholesterol. On top of that core sits a growing library of premium health reports — cardiovascular, methylation, micronutrient, longevity, sleep, and more — sold as an annual membership currently held by approximately 1,000 members, plus a branded supplement line matched to the genetic results. This is a product with demonstrated durable product-market fit. It launched in 2018, has served thousands of customers, and has generated revenue continuously since. The twenty-diet-type framework is what customers connect with, talk about, and return for: an identity and a plan rather than a raw data dump. Customer acquisition runs on SEO, organic search, email, and word of mouth, supported by HSA/FSA eligibility and inbound demand from clinics and integrative-medicine practitioners. The business is profitable and capital efficient. Revenue grew from under $60,000 to $555,300 in three years while remaining profitable every year. In 2025 it generated $327,200 in seller's discretionary earnings — a 59% SDE margin — on a fully remote operation with no full-time employees and approximately 79% gross margins. The platform has also proven it can extend. A 2025 supplement line and a 2026 environmental-genomics release were both built and shipped on modest budgets using the existing architecture, and a consented research cohort has been accumulating alongside the core business. These represent optionality on top of a proven cash-generating core. Highlights:$555,300 revenue in 2025 | $327,200 SDE | ~79% gross marginsEight consecutive years of sales on the core DNA nutrition product, launched 2018~110% three-year revenue CAGR (FY22 $58.5K → FY25 $555.3K); SDE up from $29.9K to $327.2KProprietary twenty-diet-type taxonomy built on 200 vetted genetic factors, each carrying an internal Science Grade derived from a two-year peer-reviewed literature reviewAI engine generating personalized meal plans and nutrition protocols directly from genetic resultsApproximately 1,000 members paying annual fees — an established subscription layer built without a dedicated conversion programTwo acquisition paths into the core product: physical test kits fulfilled through a CLIA-certified lab, and near-zero-COGS analysis of raw data uploaded from 23andMe and Ancestry2025 supplement line with repeat-purchase behaviorDemonstrated B2B demand from wellness clinics, IV clinics, functional-medicine providers, and physiciansStrong SEO, low CAC, HSA/FSA eligibleLean and remote: owner part-time plus four independent contractors, no physical overheadConsented, transferable genome environment research dataset — a monetization path not yet activated

Cash Flow $327,191
Revenue $555,256

loading...
TOP ▲
Add Businesses and/or Franchises
To Basket For Free Information

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our cookies information for more details.